您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Anticancer Drugs Market Report

健康网讯：

Research Report on Chinese Anticancer Drugs Market

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$3,100 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com

Table of contents
1 Categories and action mechanism of anticancer drugs
  1.1 Categories of main anticancer drugs
  1.2 Summary of action mechanism
2 Market analysis of anticancer drugs
  2.1 Market scale and growth trend
    2.1.1 Theoretical market scale 
    2.1.2 Growth trend
  2.2 Market shares of different categories
  2.3 Market shares of different breeds
  2.4 Leading manufacturing enterprises and sales value
  2.5 Prospect of main breeds
  2.6 Market shares of joint venture, foreign, joint venture
 enterprises
3  Sales analysis of representative anticancer drugs
  3.1 Alkylating agent
      Ifosfamide
      Nitrosoureas
  3.2 Anticancer antibiotics
      Epirubicin
      Pirarubicin
      Mitomycin
      Doxorubicin
  3.3 Antimetabolites
      Gemcitabine
      Capecitabine
      Doxifluridine
      cytosine arabinoside
  3.4 plant-originated anticancer drugs
      Paclitaxel
      Docetaxel
      Vinorelbine
      hydroxycamptothecin
  3.5 Hormone Agent
      Triptorelin
      Flutamide
      Leuprorelin
      Toremifene
      Anastrozole
      Tamoxifen
      Goserelin
  3.6 Platinum agent
      Oxaliplatin
  3.7 Others
      Rituximab(Rituxan)
      Imatinib(Gleevec)
4 Sales analysis of non-representative anticancer drugs
      Immune Regulators of Chinese traditional medicine
      Chines traditional medicine with anticancer action
      Pamidronate Disodium